Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreas Cancer · Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Ashley Donihee) · zwz6jm@uvahealth.org · 434-243-6377
Contact: Study coordinator (Sara Casana-Granell) · QNA7WG@uvahealth.org · 434-924-5254
Contact: Principal Investigator (Tri Le, MD, DSc)

Study leads

Tri Le, MD, DSc
Principal Investigator
University of Virginia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

End of Life · Cancer

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Pancreas Cancer · Periampullary Cancer · Periampullary Carcinoma Resectable

Abroad (travel likely)RecruitingPHASE3

Minya, Egypt